104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

Pereyra-Rodriguez, Jose Juan; Dominguez-Cruz, Javier; Armario-Hita, Jose Carlos; Ruiz-Villaverde, Ricardo

Pereyra-Rodriguez, Jose Juan; Dominguez-Cruz, Javier; Armario-Hita, Jose Carlos; Ruiz-Villaverde, Ricardo.

Pereyra-Rodriguez, Jose Juan; Hospital Universitario Virgen del Rocio. Dermatology Unit. Sevilla. ES
Dominguez-Cruz, Javier; Hospital Universitario Virgen del Rocio. Dermatology Unit. Sevilla. ES
Armario-Hita, Jose Carlos; Hospital Universitario Puerto Real. Dermatology Unit. Cádiz. ES
Ruiz-Villaverde, Ricardo; Hospital Universitario San Cecilio. Dermatology Unit. Granada. ES

An. bras. dermatol ; 96(6): 787-790, Nov.-Dec. 2021. tab, graf

Article in English | LILACS | ID: biblio-1355627

Subject(s)

Humans; Dermatitis, Atopic/drug therapy; Dermatology; Spain; Severity of Illness Index; Double-Blind Method; Treatment Outcome; Antibodies, Monoclonal, Humanized

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Dermatitis, Atopic / Dermatology Type of study: Controlled clinical trial Limits: Humans Country/Region as subject: Europa Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2021 Type: Article Affiliation country: Spain Institution/Affiliation country: Hospital Universitario Puerto Real/ES / Hospital Universitario San Cecilio/ES / Hospital Universitario Virgen del Rocio/ES

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google